Lantern Pharma and Panna Sharma News

This is selected news for Lantern Pharma and Panna Sharma, which are filed under Sectors / Healthtech and People, respectively. There are 42 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
12/2/2022 Lantern Pharma to Participate at the RHK Capital Disruptive
DALLAS, via InvestorWire -- Lantern Pharma Inc (Nasdaq: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announces that Panna Sharma, CEO and President, will present ...
Globe Newswire
11/22/2022 RHK Capital to Host 2022 Disruptive Growth Conference in
... resources, technology, logistics, electric vehicles and biotechnology. Invited speakers include Mark Emalfarb, CEO of Dyadic International, Inc.; Ram Makunda, CEO of India Globalization Capital, Inc.; Panna Sharma, CEO and president of Lantern Pharma Inc.; Adam Michaels, CEO of Mamamancini's Holdings Inc.; Bill Haydon, chief investment officer and chief credit officer ...
Globe Newswire
11/22/2022 RHK Capital to Host 2022 Disruptive Growth Conference in NYC on Dec. 5-6
... biotechnology. Invited speakers include Mark Emalfarb, CEO of Dyadic International, Inc.; Ram Makunda, CEO of India Globalization Capital, Inc.; Panna Sharma, CEO and president of Lantern Pharma Inc.; Adam Michaels, CEO of Mamamancini's Holdings Inc.; Bill Haydon, chief investment officer and chief credit officer of Sachem Capital Corp.; and Trust ...
Yahoo News
11/22/2022 RHK Capital to Host 2022 Disruptive Growth Conference in NYC on Dec. 5-6
... resources, technology, logistics, electric vehicles and biotechnology. Invited speakers include Mark Emalfarb, CEO of Dyadic International, Inc.; Ram Makunda, CEO of India Globalization Capital, Inc.; Panna Sharma, CEO and president of Lantern Pharma Inc.; Adam Michaels, CEO of Mamamancini's Holdings Inc.; Bill Haydon, chief investment officer and chief credit ...
forextv.com
11/8/2022 Lantern Pharma Inc. (LTRN) Q3 2022 Earnings Call Transcript
Lantern Pharma Inc. (LTRN) Q3 2022 Earnings Call Transcript [Lantern Pharma Inc. (LTRN)] Lantern Pharma Inc. (NASDAQ: LTRN ) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Panna Sharma - President and CEO David Margrave - CFO Nicole Leber - Investor Relations Conference Call Participants John Vandermosten - Zacks Research ...
Seeking Alpha
11/7/2022 Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights | Business | The Daily News
... and with new molecules and combinations that we have been validating with both AI-guided development and in highly targeted wet-lab studies,‚Au stated Panna Sharma, CEO and President of Lantern Pharma. ‚AuThe compression of costs and timeline, that we are creating with our drug development process, have allowed ...
galvnews.com
11/2/2022 Lantern Pharma Management to Present at Upcoming Investor Conferences in Q4
DALLAS--(BUSINESS WIRE)--Nov 2, 2022-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Lantern management will be ...
Business Wire
11/2/2022 Stock Market | FinancialContent Business Page
... management will be presenting at two upcoming investor conferences: BioFuture Conference in New York, NY on Tuesday, November 8 th , 2022 at 2:00 p.m. ET. Panna Sharma, CEO & President, and David Margrave, CFO, will present. Registration: https://biofuture.com/biofuture-registration/ Disruptive Growth Conference in New York, NY from December 5-6 ...
financialcontent.com
10/31/2022 Lantern Pharma to Report Third Quarter 2022 Operating & Financial Results on November 7, 2022 at 4:30 p.m. ET | Business Wire
DALLAS--( BUSINESS WIRE )-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence (A.I.) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will host its third quarter 2022 financial ...
Business Wire
10/31/2022 Lantern Pharma to Report Third Quarter 2022 Operating & Financial Results on November 7, 2022 at 4:30 p.m. ET
... Pacific Time. Management intends to discuss the operating and financial results for the third quarter ended September 30, 2022 and provide guidance on upcoming milestones. Panna Sharma, President and Chief Executive Officer of Lantern Pharma, will lead the call and will be joined by other members of the management team ...
Business Wire
10/21/2022 Lantern Pharma to Present at the ThinkEquity Conference on Wednesday, October 26 at 1:00 p.m. ET | Business | The Daily News
DALLAS--(BUSINESS WIRE)--Oct 21, 2022-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Lantern management will be ...
galvnews.com
10/21/2022 Lantern Pharma to Present at the ThinkEquity Conference on Wednesday, October 26 at 1:00 p.m. ET
... development, today announced that Lantern management will be presenting at the ThinkEquity Conference, which is being held on October 26th, 2022 in New York, NY. - Panna Sharma, Lantern's CEO & President, will be hosting an A.I. and Drug Development Panel at 10:00 a.m. ET focused on how A.I. is transforming ...
metrolatinousa.com
10/21/2022 2022-10-21 | NDAQ:LTRN | Press Release | Lantern Pharma Inc.
LTRN 3 days ago Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("A.I.") and machine learning (‚AuM.L.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Lantern management will be presenting at ...
stockhouse.com
10/11/2022 Lantern Pharma to Present at The MicroCap Rodeo Presents The Windy City Roundup 2022 on Wednesday, October 12 at 11:00 a.m. ET
... Microcap Rodeo presents The Windy City Roundup 2022 conference, which is being held live, in-person on October 12 th - 13 th , 2022. CEO & President, Panna Sharma will present at the conference. Lantern Pharma is scheduled to present on Wednesday, Oct. 12 th at 11:00 a.m. ET/10:00 a.m. CT ...
Yahoo News
10/11/2022 DALLAS, TX / ACCESSWIRE / October 11, 2022 / Lante
DALLAS, TX 11, 2022 / Lantern Pharma Inc. (NASDAQ:LTRN) , a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning ("M.L.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, has been invited to present at the Microcap Rodeo presents ...
wapakdailynews.com
10/11/2022 Lantern Pharma to Present at The MicroCap Rodeo Presents The Windy City Roundup 2022 on Wednesday, October 12 at 11:00 a.m. ET
... Microcap Rodeo presents The Windy City Roundup 2022 conference, which is being held live, in-person on October 12 th - 13 th , 2022. CEO & President, Panna Sharma will present at the conference. Lantern Pharma is scheduled to present on Wednesday, Oct. 12 th at 11:00 a.m. ET/10:00 a.m. CT ...
winslowevanscrocker.com
10/5/2022 Lantern Pharma to Present at Upcoming Investor Conferences
DALLAS--(BUSINESS WIRE)--Oct 5, 2022-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Lantern management will be ...
Business Wire
10/5/2022 Lantern Pharma to Present at Upcoming Investor Conferences
... presenting at two upcoming investor conferences: MicroCap Rodeo Presents: Windy City Roundup in Chicago, IL on Wednesday, October 12 at 10:00 a.m. CT. CEO & President Panna Sharma will present. Webcast Link: https://www.webcaster4.com/Webcast/Page/2924/46673 Registration Link: https://microcaprodeo.com/signup ThinkEquity Conference in New York, NY on Wednesday ...
Yahoo News
10/5/2022 Stock Market | FinancialContent Business Page
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Lantern management will be presenting at two upcoming investor conferences ...
financialcontent.com
8/19/2022 19 | NDAQ:LTRN | Press Release | Lantern Pharma Inc.
... Bloomberg TV is available in an estimated 73 million homes across the U.S. Interview highlights: In the exclusive RedChip Money Report interview, Lantern Pharma's CEO Panna Sharma discusses the Company's cancer-focused A.I. platform RADR®, how RADR® can help lower drug development costs, the Company's diverse portfolio which ...
stockhouse.com
8/9/2022 Lantern Pharma Inc.'s (LTRN) CEO Panna Sharma on Q2 2022 Results - Earnings Call Transcript
Lantern Pharma Inc.'s (LTRN) CEO Panna Sharma on Q2 2022 Results - Earnings Call Transcript Lantern Pharma Inc. (NASDAQ:LTRN) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Nicole Leber ‚Ai Investor Relations Panna Sharma ‚Ai Chief Executive Officer David Margrave ‚Ai Chief Financial Officer ...
Seeking Alpha
8/1/2022 Lantern Pharma to Report Second Quarter 2022 Operating & Financial Results on August 8th, 2022 at 4:30 p.m. ET
... Pacific Time. Management intends to discuss the operating and financial results for the second quarter ended June 30, 2022 and provide guidance on upcoming milestones. Panna Sharma, President and Chief Executive Officer of Lantern Pharma, will lead the call and will be joined by other members of the management team ...
Business Wire
3/25/2021 Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference
... she said it's a signal a company has a cash runway. The following are biotech companies that investors heard from at the Benzinga conference. Presentations Lantern Pharma Inc. (NASDAQ: LTRN ): Lantern CEO Panna Sharma recommends leveraging data especially on similar classes of drugs in the market and early data ...
Benzinga
3/11/2021 Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q4 2020 Results - Earnings Call Transcript
Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q4 2020 Res‚A¶ Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q4 2020 Results - Earnings Call Transcript SeekingAlpha ...
onenewspage.us
11/24/2020 Lantern Pharma Announces Upcoming Conference Presentations - Nov 24, 2020
Lantern Pharma Announces Upcoming Conference Presentations - Nov 24, 2020 Published: Nov 24, 2020 DALLAS , Nov. 24, 2020 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") platform to transform the pace, risk and cost of oncology drug discovery and development, and ...
BioSpace